Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Haemonetics Corporation

    NYSE: HAE · Real-Time Price · USD
    69.97
    -0.12 (-0.17%)
    At close: Jun 16, 2025, 3:59 PM
    69.96
    -0.01%
    After-hours: Jun 16, 2025, 06:27 PM EDT

    Haemonetics Statistics

    Share Statistics

    Haemonetics has 48.04M shares outstanding. The number of shares has increased by -1.4% in one year.

    Shares Outstanding

    n/a
    		 48.04M

    Shares Change (YoY)

    n/a
    		 -1.4%

    Shares Change (QoQ)

    n/a
    		 0.03%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 47.37M

    Failed to Deliver (FTD) Shares

    n/a
    		 17

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 4.12M, so 8.57% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.12M

    Short % of Shares Out

    n/a
    		 8.57%

    Short % of Float

    n/a
    		 13.93%

    Short Ratio (days to cover)

    n/a
    		 9.04

    Valuation Ratios

    The PE ratio is 18.97 and the forward PE ratio is 14.71. Haemonetics's PEG ratio is 0.44.

    PE Ratio

    n/a
    		 18.97

    Forward PE

    n/a
    		 14.71

    PS Ratio

    n/a
    		 2.34

    Forward PS

    n/a
    		 2.2

    PB Ratio

    n/a
    		 3.87

    P/FCF Ratio

    n/a
    		 22.33

    PEG Ratio

    n/a
    		 0.44
    Financial Ratio History

    Enterprise Valuation

    Haemonetics has an Enterprise Value (EV) of 3.18B.

    EV / Sales

    n/a
    		 2.33

    EV / EBITDA

    n/a
    		 14.32

    EV / EBIT

    n/a
    		 17.48

    EV / FCF

    n/a
    		 22.3

    Financial Position

    The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.37.

    Current Ratio

    n/a
    		 1.62

    Quick Ratio

    n/a
    		 0.99

    Debt / Equity

    n/a
    		 0.37

    Debt / EBITDA

    n/a
    		 1.37

    Debt / FCF

    n/a
    		 2.13

    Interest Coverage

    n/a
    		 -22.76

    Financial Efficiency

    Return on Equity is 20.43% and Return on Invested Capital is 8.06%.

    Return on Equity

    n/a
    		 20.43%

    Return on Assets

    n/a
    		 6.84%

    Return on Invested Capital

    n/a
    		 8.06%

    Revenue Per Employee

    n/a
    		 $372,114.85

    Profits Per Employee

    n/a
    		 $45,851.52

    Employee Count

    n/a
    		 3,657

    Asset Turnover

    n/a
    		 0.56

    Inventory Turnover

    n/a
    		 1.68

    Taxes

    Income Tax

    n/a
    		 44.39M

    Effective Tax Rate

    n/a
    		 20.93%

    Stock Price Statistics

    The stock price has increased by -17.27% in the last 52 weeks. The beta is 0.37, so Haemonetics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.37

    52-Week Price Change

    n/a
    		 -17.27%

    50-Day Moving Average

    n/a
    		 65.12

    200-Day Moving Average

    n/a
    		 72.08

    Relative Strength Index (RSI)

    n/a
    		 57.39

    Average Volume (20 Days)

    n/a
    		 636,353

    Income Statement

    In the last 12 months, Haemonetics had revenue of 1.36B and earned 167.68M in profits. Earnings per share was 3.31.

    Revenue

    n/a
    		 1.36B

    Gross Profit

    n/a
    		 748.96M

    Operating Income

    n/a
    		 221.82M

    Net Income

    n/a
    		 167.68M

    EBITDA

    n/a
    		 221.82M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 3.31
    Full Income Statement

    Balance Sheet

    The company has 306.76M in cash and 303.56M in debt, giving a net cash position of 3.21M.

    Cash & Cash Equivalents

    n/a
    		 306.76M

    Total Debt

    n/a
    		 303.56M

    Net Cash

    n/a
    		 3.21M

    Retained Earnings

    n/a
    		 352.17M

    Total Assets

    n/a
    		 2.45B

    Working Capital

    n/a
    		 356.86M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 181.72M and capital expenditures -39.28M, giving a free cash flow of 142.45M.

    Operating Cash Flow

    n/a
    		 181.72M

    Capital Expenditures

    n/a
    		 -39.28M

    Free Cash Flow

    n/a
    		 142.45M

    FCF Per Share

    n/a
    		 2.83
    Full Cash Flow Statement

    Margins

    Gross margin is 55.04%, with operating and profit margins of 16.3% and 12.32%.

    Gross Margin

    n/a
    		 55.04%

    Operating Margin

    n/a
    		 16.3%

    Pretax Margin

    n/a
    		 15.58%

    Profit Margin

    n/a
    		 12.32%

    EBITDA Margin

    n/a
    		 16.3%

    EBIT Margin

    n/a
    		 16.3%

    FCF Margin

    n/a
    		 10.47%

    Dividends & Yields

    HAE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 5.27%

    FCF Yield

    n/a
    		 4.48%
    Dividend Details

    Analyst Forecast

    The average price target for HAE is $100, which is 42.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $100

    Price Target Difference

    n/a
    		 42.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $53.26

    Lynch Upside

    n/a
    		 -23.96%

    Graham Number

    n/a
    		 34.96

    Graham Upside

    n/a
    		 -50.09%

    Stock Splits

    The last stock split was on Dec 3, 2012. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Dec 3, 2012

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 2.29

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist